Related Experiment Video
Updated: Mar 28, 2026
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Blood biomarkers as surrogate endpoints in Alzheimer's disease research
Guogen Shan1, Hui Li2, Yahui Zhang1
1Department of Biostatistics, University of Florida, Gainesville, FL, United States.
Background:
Blood biomarkers for Alzheimer's disease (AD) can be utilized as surrogate endpoints to accelerate therapeutic development for this condition.
Methods:
We assessed the association between short-term changes in blood biomarkers and long-term declines in cognitive and brain structure volume measures using the ADNI database, with a focus on amyloid-β (Aβ)-positive participants. In our statistical models, the association was calculated after controlling for age, sex, and other possible confounding covariates. Additionally, outliers were removed before running the statistical models to ensure that the results were robust.
Results:
A trend association was found between changes in the levels of plasma neurofilament light (NfL) at 12 months and changes in the scores on the Mini-Mental State Examination (MMSE) at 24 months in Aβ-positive mild cognitive impairment (MCI) patients. For Aβ-positive dementia patients, a trend association was observed between changes in plasma p-tau181 levels and changes in whole brain and middle temporal volume.
Conclusion:
Increased plasma levels of NfL or p-tau181 blood biomarkers were found to be associated with reduced brain volumes and/or declined cognitive outcomes, suggesting that these blood biomarkers may have a predictive role in AD trials.
More Related Videos
07:28Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
Published on: May 19, 2022
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Related Concept Videos
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:22Alzheimer's Disease: Treatment
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...